Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for out-of-proportion pulmonary hypertension with moderate left ventricular dysfunction
2010-022820-61Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tadalafil in pulmonary hypertension (PH) and left ventricular dysfunction, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Pulmonary vascular resistance by right heart catheterization. Started Dec 2010; status: active.
02
Drugs
tadalafil
03
Conditions
pulmonary hypertension (PH)left ventricular dysfunction
Beyond the preview
Go deeper on 2010-022820-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022820-61.